Status:
COMPLETED
Work Productivity in Hyperventilation Syndrome
Lead Sponsor:
University Hospital, Lille
Conditions:
Hyperventilation Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Hyperventilation syndrome is associated with impaired quality of life. The aim of the study is to assess the relationship between work productivity, including absenteeism and presenteeism, and the sev...
Eligibility Criteria
Inclusion
- Holders of employment contracts for at least 8 days
- Diagnosis of hyperventilation syndrome confirmed by:
- Compatible symptoms and at least two symptoms reproduced by the hyperventilation challenge test: Nijmegen's score\> 23 ; Demonstration of alveolar hyperventilation ( Either on rest blood and / or at rest (PaCO2 at rest \<36 mmHg and D (A-a) O2 normal; Either during the HV test (increased recovery time of the basic PETCO2 after voluntary hyperventilation (greater than 5 minutes)
Exclusion
- Existence of another chronic pulmonary disease (asthma, bronchial dilation, COPD, diffuse interstitial pneumonia, neuromuscular pathology ...) or cardiac (rhythm disorder, ischemic heart disease ...) which can participate in dyspnea
- Psychiatric illness / psychotropic treatment
- Pregnancy
- Patient already included in a clinical research protocol involving new therapeutics may not be included in this protocol
- Specific physiotherapy or previous training
Key Trial Info
Start Date :
February 6 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 23 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03292523
Start Date
February 6 2018
End Date
February 23 2021
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Calmette,CHU
Lille, France